Form 4 for AORT ARTIVION, INC.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001628280-26-014894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +21.8K | 62.2K | +54% | $0 | |
| 2026-03-04 | 2026-03-03 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $37.78 | -2,149 | 60.1K | -3% | -$81.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | A | A | 21,838 | $0.00 | 62,246 | D | — | — | (F1) Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. |
| 2 | Common | Common Stock | 2026-03-03 | S | D | 2,149 | $37.78 | 60,097 | D | — | — | (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |